Cortex Pharma Q2 net loss shrinks - Pharmaceutical Business review

17 Aug 2011

Cortex Pharma Q2 net loss shrinks

Cortex Pharmaceuticals has reported net loss of $356,000 for the second quarter ended 30 June 2011, compared to $2.45m for the same period in 2010.

The company’s loss from operations for the second quarter of 2011 was $364,000, compared to $1.97m for the same period in 2010.

For the six months ended 30 June 2011, the company reported a net loss of $1.91m, compared to $3.14m for the same period in 2010.

Cortex Pharma’s operating loss was $1.92m for the six months of 2011, compared to $3.14m for the same period in 2010.

Drug Discovery